Midmark Midmark Digital ECGRecalls & reported problems
Cardioline SPA · ECG acquisition capabilities to resting ECG and stress test systems. (Wireless acquisition module) · Class 2
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08056732652491), received between May 2, 2024 and May 2, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “High Readings” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Jul 20, 2026Open, Classified
A communication anomoly may result in incorrect electrocardiogram waveforms of a patient and an inaccurate beats-per-minute calculation.
Z-3013-2026 · Root cause: Software design · FDA record ↗
Most reported problems
Device problems
- High Readings1
- Incorrect Measurement1
- Incorrect, Inadequate or Imprecise Result or Readings1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 2, 2024Incorrect Measurement; Incorrect, Inadequate or Imprecise Result or Readings; High Readings; Incorrect Measurement; Incorrect, Inadequate or Imprecise Result or Readings; High Readings
IT WAS REPORTED THAT HIGH HEART RATES FROM 7 ECG DEVICES WERE SHOWN ON THE ECG REPORTS. THE FOLLOWING SERIAL NUMBERS ARE: (B)(6) THE CUSTOMER STATED THAT THE DOUBLING OF HEART RATES WERE SEEN ON A SINGLE PATIENTS ECG REPORT. A PATIENT WAS PRESCRIBED HEART MEDICATION (CARDIZEM) AS THEIR REPORT SHOWED HIGH HEART RATE. THE MEDICATION WAS NOT CONSUMED BY THE PATIENT AND TACHYCARDIA WAS RULED OUT BY A LIVE HOLTER MONITORING DEVICE. TECHNICAL SERVICE REACHED OUT TO THE CUSTOMER TO TROUBLESHOOT AND WAS UNABLE TO RECREATE THE ISSUE WITH THE ECG UNITS USED. THERE WAS NO PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19234611 ↗
Other Transmitters And Receivers, Physiological Signal, Radiofrequency devices
- NA ORG-9110ANihon Kohden Corporation · TRANSMITTERS AND RECEIVERS, PHYSIOLOGICAL SIGNAL, RADIOFREQUENCY272 reports
- NA GZ-130PNihon Kohden Corporation · TRANSMITTERS AND RECEIVERS, PHYSIOLOGICAL SIGNAL, RADIOFREQUENCY1 death203 reports
- NA ORG-9100ANihon Kohden Corporation · TRANSMITTERS AND RECEIVERS, PHYSIOLOGICAL SIGNAL, RADIOFREQUENCY106 reports
- Vital Sync VITALSYNCSW03Covidien LP · TRANSMITTERS AND RECEIVERS, PHYSIOLOGICAL SIGNAL, RADIOFREQUENCY1 recall1 report
- Vital Sync VITALSYNCSW03Covidien LP · TRANSMITTERS AND RECEIVERS, PHYSIOLOGICAL SIGNAL, RADIOFREQUENCY1 recall1 report
- VistaCenter 6200-01Vital Connect, Inc. · Transmitters And Receivers, Physiological Signal, Radiofrequency1 recall1 report
- BioButton v3 (BBN-r, different batch) BIOST06040Biointellisense, Inc. · Transmitters And Receivers, Physiological Signal, Radiofrequency1 recall0 reports
- Patient Monitor elite V5Edan Instruments, Inc. · Transmitters And Receivers, Physiological Signal, Radiofrequency1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.